Osage University Partners was among the participants in a round led by Ignition Partners that will help KenSci further develop its machine learning technology.

AnaptysBio, which filed for the IPO in 2015, has gone public in an offering that will give long-term investor Novo an exit.

Novo and Merck Group have exited ObsEva in an offering that involved the reproductive health treatment developer floating in the middle of its range.

The Singaporean state-owned firm will acquire a minority stake in Alphabet's life sciences spinout and will take a board seat in the process.

Personal cardiac monitor developer Personal MedSystems has secured $5.4m in a round backed by KPN's corporate venturing subsidiary, Personal MedSystems.

Albert Einstein College of Medicine spinout Cue Biopharma has secured $26m in funding across two rounds led by investment bank MDB Capital Group.

HD Biosciences, a contract drug research services provider backed by Pfizer and Eli Lilly, has been acquired by WuXi AppTec for an undisclosed sum.

Takeda has made an equity investment in new strategic partner Ovid Therapeutics as part of a round sized at $25.9m, according to a securities filing.

Industrial park Beijing E-Town Biomedical Park has invested in Mabworks Biotech, which is working on antibody drugs for cancer and Ebola.

The Bath University spinout will use the series D proceeds to fund clinical trials of a test for chlamydia and gonorrhoea while expanding its partner's manufacturing capacity.